In this context, the IL-1RN and IL-1β genes play critical roles in the regulation of the inflammatory response, with genetic variants in these genes potentially influencing the levels of this cytokine and increasing the risk of CRC. The gene discussed is IL1B; the disease is colorectal carcinoma.